Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-10-31
1988-12-27
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
047941154
ABSTRACT:
A method of treating or preventing hyperlipemia by administering ethanolamine derivatives. As preferable ethanolamine derivatives are mentioned N-(9,12,15,-octadecatrienoyl)-2-aminoethyl nicotinate, N-(5,8,11,14,17-eicosapentaenoyl)-2-aminoethyl nicotinate and the like. Hyperlipemia is effectively prevented or treated by administering 300-2000 mg per day of said ethanolamine derivative for adults.
REFERENCES:
Takahashi et al., Chem. Abst. 107:39501s (1987), abstracting Belgian Patent No. 901,987 issued Jul. 16, 1985.
Seki et al., "Studies on Hypolipidemic Agents I. Synthesis and Pharmacological Properties of Nicotinic Acid-Ethanolamine Derivatives", Chem. Pharm. Bull 31(11) 4116-4126 (1983).
Takahashi Keiko
Wakabayashi Toshio
Kearse Richard
Robinson Allen J.
Terumo Corporation
LandOfFree
Method of treating hyperlipemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hyperlipemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperlipemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-868219